Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

President Calls For Almost $100M More In Funding For FDA Device Activities In 2020

Executive Summary

The current administration would use an additional $98m in congressional budget authority in the 2020 fiscal year for FDA’s medical device efforts to modernize its regulatory approach for technology development, to enable device safety issues to be monitored more closely, and to advance new approaches for regulating digital health technologies and breakthrough devices.

Advertisement

Related Content

Scott Gottlieb Calls It Quits After An Active Tenure At US FDA
CDRH Will Experiment With Pre-Cert Pilot Participants To Figure Out Right Metrics, Processes
Pre-Cert Program Will Start Off Slow With De Novo Framing, But Big Questions Remain
21st Century Cures Implementation: Device Provision Updates

Topics

Advertisement
UsernamePublicRestriction

Register

MT124772

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel